Your session is about to expire
← Back to Search
Community Support & Education for Opioid Use Disorder (CENS Trial)
CENS Trial Summary
This trial evaluates an intervention to reduce opioid-related risk behaviors in veterans with opioid use disorder. It involves peer outreach workers, educational sessions, healthcare navigation & social support. Findings will benefit community & civic healthcare orgs that provide overdose/HIV risk reduction.
CENS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCENS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CENS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I cannot speak English.
- Group 1: CENS Intervention
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the size of the participant pool for this research endeavor?
"Affirmative. According to the data on clinicaltrials.gov, this trial is presently recruiting patients and was first published on October 21st 2022. The most recent update took place June 29th 2023 and 300 participants need to be recruited from 1 location."
Is the enrollment process for this trial still open?
"Affirmative. The information on clinicaltrials.gov shows that this medical research is actively searching for participants, which began to be recruited since October 21st 2022 and was last updated June 29th 2023. 300 patients will be incorporated in the study from a single location."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger